COGVIC

COGVIC catalogs germline pathogenic and likely pathogenic variants associated with cancer predisposition in East Asian pan-cancer patients to provide a population-specific resource for genetic and clinical analyses.

Key Features:

• Comprehensive Data Collection: Aggregates publicly available datasets to identify and catalogue 233 germline pathogenic or likely pathogenic variants observed in East Asian cancer cohorts.
• Population-Specific Insights: Reports population-specific allele and gene differences, noting that 87% of genes with pathogenic variants in the East Asian cohort are not shared with Caucasian cohorts, including genes such as BRCA2.
• Comparative Analysis: Compares East Asian variant data with existing Caucasian cohort data to highlight unique genetic predispositions across populations.

Scientific Applications:

• Cancer genetics research: Supports studies of germline cancer predisposition and variant interpretation specifically in East Asian cohorts.
• Clinical risk assessment: Provides a curated set of germline pathogenic variants to inform hereditary cancer risk evaluation in East Asian patients.
• Personalized medicine and screening: Informs targeted screening programs and personalized medicine approaches tailored to East Asian genetic backgrounds.

Methodology:

Systematic investigation and aggregation of publicly available data to identify and catalogue germline variants in East Asian cancer cohorts, followed by comparison of these findings with existing data from Caucasian populations.